Pet Healthcare in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The Japanese Pet healthcare market recorded revenues of $976.5 million in 2023, representing a compound annual growth rate (CAGR) of 3.3% between 2018 and 2023.
- Market consumption volume increased with a CAGR of 2.6% between 2018 and 2023, to reach a total of 164.4 million units in 2023.
- The performance of the market is forecast to accelerate, with an anticipated CAGR of 4% over 2023-28, which is expected to drive the market to a value of $1.18 billion by the end of 2028.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pet healthcare market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in Japan
- Leading company profiles reveal details of key pet healthcare market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pet healthcare market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Japan pet healthcare market by value in 2023?
- What will be the size of the Japan pet healthcare market in 2028?
- What factors are affecting the strength of competition in the Japan pet healthcare market?
- How has the market performed over the last five years?
- Who are the top competitors in Japan's pet healthcare market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Virbac Group
- Elanco Animal Health Inc
- Fujita Pharmaceutical Co.,Ltd.
